According to the new market research report, "Chiral Chromatography Column Market by Technology (GC, LC, TLC, Flash Chromatography), type (Empty, Prepacked, Analytical, Preparative), Material (Metal, Glass, Plastic), Enduser (Hospital,Food, Pharma-Biotech, Environmental - Global Forecast to 2025"The chiral chromatography column marketsize is projected to reach USD 123 million by 2025 from an estimated USD 99 million in 2020, at a CAGR of4.5% during the forecast period.

Download PDF Brochure@ https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=225453435

Global Industry Growth Boosting Factors:

Increasing R&D investments in the pharmaceutical and biotechnology industry is driving the growth of the market. Moreover, growth opportunities in emerging countries as well asthe emergence of green chemistry,is likely to provide opportunities forthe chiral chromatography column industry.

Overview:

This study involved four major activities in estimating the current size of the chiral chromatography column market. Exhaustive secondary research was done to collect information on the market, peer market, and parent market. The next step was to validate these findings, assumptions, and market sizing with industry experts across the value chain through primary research. Both top-down and bottom-up approaches were used to estimate the total market size. After that, the market breakdown and data triangulation were done to determine the market size of the segments and sub-segments.

Driver: Increasing R&D investments in the pharmaceutical and biotechnology industry

Chromatography is a versatile separation technique that is used across many industries such as biopharmaceutical & pharmaceutical, food & beverage, oil & petroleum, environmental testing, and agriculture & chemical. Pharmaceutical and biotechnology companies are investing significant amounts of their revenue in research to come up with breakthrough protein-related products to meet the growing needs of the healthcare sector. Chromatography, spectroscopy, PCR, flow cytometry, and NGS are common technologies used in proteomic research. Moreover, pharmaceutical and biotechnology companies are increasingly adopting these technologies for protein separation and identification during drug discovery and development.

Request FREE Sample Pages@ https://www.marketsandmarkets.com/requestsampleNew.asp?id=225453435

Restraints: Lack of skilled professionals

The proper use of analytical technologies such as chromatography, PCR, and NGS requires expertise with relevant experience and knowledge. Various technological innovations in the chiral chromatography columns market are increasing the need for skilled professionals who can effectively operate chiral chromatography columns. For instance, an inconsistent column packing can result in low purity levels and product yield, which would, in turn, impact the quality of the final product. Moreover, the selection of the right chromatography technique (specific to a given task) plays a crucial role in the purification process. The lack of knowledge regarding the right choice of technique incurs several direct and indirect expenses and increases the time to market the drugs.

Opportunities: Growth opportunities in emerging countries

Many developing economies, such as India, China, Brazil, Russia, Taiwan, and South Korea, offer high-growth opportunities for major market players in the life science instrumentation market owing to the increasing growth opportunities for analytical instruments. Although the adoption of advanced technologies is low in developing countries, their huge population base and increasing research activities, especially in India and China, are expected to offer a sustainable market for life science instruments. Furthermore, with the increasing number of greenfield projects and rising capital expenditure on infrastructure development, these countries are offering potential growth avenues for market players

Challenges: Inadequate infrastructure for research in emerging countries

Adequate infrastructure for research, coupled with a skilled workforce, financial support, and basic research laboratories, are the key prerequisites for the use of chiral chromatography techniques for research. However, emerging countries in Asia (such as India, Indonesia, and the Philippines), the Middle East (such as Oman, Iraq, and UAE), and Africa lack the required infrastructure. For instance, in India, of the 4,168 private laboratories in the state of Kerala, only 7% have the National Accreditation Board for Testing and Calibration Laboratories (NABL) accreditation or ISO certification

By the end-user, the pharmaceutical & biotechnology companies segment is expected to make the most significant contribution to the chiral chromatography column market during the forecast period.

Pharmaceutical and biotechnology companies are among the key end users of chiral chromatography columns. They use analytical instrumentation during various stages of biopharmaceutical and pharmaceutical drug discovery, drug research and development, pharmacokinetics, toxicology, and clinical studies.

Speak to Analyst for More Detailed Information@ https://www.marketsandmarkets.com/speaktoanalystNew.asp?id=225453435